Table 3. Sensitivity assay results and patients treatment.

	SN003	LG004	GD006	TR008	GA010	PD019	CV020
Marker
CD133	55%	60%	70%	60%	65%	55%	70%
CD166	70%	80%	80%	85%	70%	80%	65%
Oct 3/4	70%	75%	75%	70%	80%	75%	80%
ALDH1	90%	90%	80%	80%	70%	90%	80%
CD90	90%	90%	90%	90%	70%	90%	80%
Time to results (days)	37	52	95	51	44	56	50
Tested drugs (n)	5	5	5	26	26	15	18
Drugs determining mortality rate (code)
<30%	2,4,5,17,33	8,12,14,15,19	11,24,28,32	1,3,7,8,9,10,12,14,17,18,21,22,23,24,29,30,32,37,39,42,45,46	5,7,9,10,12,14,17,18,21,22,23,24,26,29,30,32,33,37,38,39,42,45,46	1,6,17,18,24,25,26,27,28,29,30,31,34,40,43	3,5,6,13,16,17,18,24,26,27,28,29,30,35,41,44,47
31–50%	0	0	17	5,25,32	1,3,8	0	36
51–75%	0	0	0	0	0	0	0
76–90%	0	0	0	38	0	0	0
>90%	0	0	0	0	0	0	0
Treatment (yes,no/drug code)	Yes/17	No/NA	Yes/17	No/NA	No/NA	Yes/6	No/NA
Response to therapy	PD	NA	SD	NA	NA	PD	NA

Abbreviations: PD, progressive disease; NA, not applicable; SD, stable disease.

Drugs and combinations are codified as in Table 1.